Friday, 18 May 2012

Vasodilan



isoxsuprine hydrochloride

Dosage Form: Tablets, USP

INDICATIONS


Based on a review of this drug by the National Academy of Sciences-National Research and/or other information, the FDA has classified the indications as follows:


Possibly Effective:


  1. For the relief of symptoms associated with cerebrovascular insufficiency.

  2. In peripheral vascular disease of arteriosclerosis obliterans, thromboangitis obliterans (Buerger's disease) and Raynaud's disease.

Final classification of the less-than-effective indications requires further investigation.



COMPOSITION


Vasodilan (isoxsuprine HCl tablets, USP) 10 mg and 20 mg. These tablets contain the following inactive ingredients: acacia, dibasic calcium phosphate, lactose, magnesium stearate, starch (corn), and talc.



Vasodilan Dosage and Administration


Oral: 10 to 20 mg, three or four times daily.



CONTRAINDICATIONS AND CAUTIONS



Oral


There are no known contraindications to oral use when administered in recommended doses. Vasodilan should not be given immediately postpartum or in the presence of arterial bleeding.



Adverse Reactions


On rare occasion oral administration of the drug has been associated in time with the occurrence of hypotension, tachycardia, chest pain, nausea, vomiting, dizziness, abdominal distress, and severe rash. If rash appears, the drug should be discontinued.


Although available evidence suggests a temporal association of these reactions with isoxsuprine, a causal relationship can be neither confirmed nor refuted.


β-Adrenergic receptor stimulants such as isoxsuprine hydrochloride have been used to inhibit pre-term labor. Maternal and fetal tachycardia may occur under such use. Hypocalcemia, hypoglycemia, hypotension and ileus have been reported to occur in infants whose mothers received isoxsuprine. Pulmonary edema has been reported in mothers treated with β-stimulants. Vasodilan (isoxsuprine HCl tablets, USP) is neither approved nor recommended for use in the treatment of premature labor.



SUPPLIED


Vasodilan® (isoxsuprine HCl tablets, USP)


10 mg


Bottles of 100         NDC 0087-0543-01


Bottles of 1000       NDC 0087-0543-02


Unit Dose               NDC 0087-0543-05


Vasodilan® (isoxsuprine HCl tablets, USP)


20 mg


Bottles of 100         NDC 0087-0544-01


Bottles of 1000       NDC 0087-0544-06



MeadJohnson Pharmaceuticals


A Bristol-Myers Squibb Company, Princeton, New Jersey 08543 U.S.A.








Vasodilan 
isoxsuprine hydrochloride  tablet










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)0087-0543
Route of AdministrationORALDEA Schedule    


























INGREDIENTS
Name (Active Moiety)TypeStrength
isoxsuprine hydrochloride (isoxsuprine)Active10 MILLIGRAM  In 1 TABLET
acaciaInactive 
dibasic calcium phosphateInactive 
lactoseInactive 
magnesium stearateInactive 
starch (corn)Inactive 
talcInactive 






















Product Characteristics
ColorWHITE (WHITE)Scoreno score
ShapeROUND (ROUND)Size9MM
FlavorImprint CodeMJ;543;10
Contains      
CoatingfalseSymbolfalse


















Packaging
#NDCPackage DescriptionMultilevel Packaging
10087-0543-01100 TABLET In 1 BOTTLENone
20087-0543-021000 TABLET In 1 BOTTLENone
30087-0543-05100 TABLET In 1 BLISTER PACKNone






Vasodilan 
isoxsuprine hydrochloride  tablet










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)0087-0544
Route of AdministrationORALDEA Schedule    


























INGREDIENTS
Name (Active Moiety)TypeStrength
isoxsuprine hydrochloride (isoxsuprine)Active20 MILLIGRAM  In 1 TABLET
acaciaInactive 
dibasic calcium phosphateInactive 
lactoseInactive 
magnesium stearateInactive 
starch (corn)Inactive 
talcInactive 






















Product Characteristics
ColorWHITE (WHITE)Scoreno score
ShapeROUND (ROUND)Size10MM
FlavorImprint CodeMJ;544;20
Contains      
CoatingfalseSymbolfalse














Packaging
#NDCPackage DescriptionMultilevel Packaging
10087-0544-01100 TABLET In 1 BOTTLENone
20087-0544-061000 TABLET In 1 BOTTLENone

Revised: 09/2006Bristol-Myers Squibb Company

More Vasodilan resources


  • Vasodilan Side Effects (in more detail)
  • Vasodilan Dosage
  • Vasodilan Use in Pregnancy & Breastfeeding
  • Vasodilan Drug Interactions
  • Vasodilan Support Group
  • 0 Reviews for Vasodilan - Add your own review/rating


  • Vasodilan Concise Consumer Information (Cerner Multum)

  • Vasodilan Advanced Consumer (Micromedex) - Includes Dosage Information

  • Vasodilan MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Vasodilan with other medications


  • Cerebrovascular Insufficiency
  • Coronary Artery Disease
  • Raynaud's Syndrome

No comments:

Post a Comment